Viridian Therapeutics Inc — Quarterly Cash Flow (NASDAQ:VRDN) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 771.9 M742.4 M660.98 M582.32 M577.14 M899.42 M Total liabilities 64.4 M70.76 M56.51 M67.16 M74.17 M177.25 M Total equity 707.5 M671.64 M604.47 M515.17 M502.97 M722.17 M Total liabilities & shareholders' equities 771.9 M742.4 M660.98 M582.32 M577.14 M899.42 M Total debt —————— Net debt ——————

新闻

Stifel重申Viridian Therapeutic股票评级,关注生物制品许可申请审查

Stifel reiterates Viridian Therapeutic stock rating on BLA review

Jefferies上调Viridian Therapeutic目标价,看好临床试验进展

Jefferies raises Viridian Therapeutic stock price target on trial progress

Evercore ISI基于数据信心重申Viridian Therapeutics股票评级

Evercore ISI reiterates Viridian Therapeutic stock rating on data conviction

Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates

Viridian TherapeuticsQ4每股收益及营收逊于预期

Viridian Therapeutics earnings missed by $0.10, revenue fell short of estimates

MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates

BB Biotech 2025财年业绩:利润飙升660%,但对2026年持谨慎态度

Truist重申Viridian Therapeutics股票评级,试验结果即将公布